FIELD: medicine.
SUBSTANCE: group of inventions refers to health monitoring in regard to function of the immune system and measurement of toxic effects and other exposures. A method involves presenting an apparatus, presenting a blood sample, setting a molecular oxygen reference value, exposing the above sample, receiving the data on molecular oxygen concentration variations and a rate of variations, as well as comparing the received data to those of a healthy individual. The apparatus comprises first and second sensors, as well as a processor unit functionally connected to the first and second sensors. There are also disclosed an apparatus for analysing the individual's immune health and a method for improving the immune system function.
EFFECT: group of inventions enables assessing and measuring an individual's immune system ability to resist a disease and give responses to drugs stimulating the immune system.
33 cl, 6 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| IMPROVING ORGANS FOR TRANSPLANTATION | 2014 |
|
RU2665364C2 |
| IMPROVEMENT OF ORGANS FOR TRANSPLANTATION | 2014 |
|
RU2778304C2 |
| PHOSPHODIESTERASE 4D7 AS PROSTATE CANCER MARKER | 2010 |
|
RU2651474C2 |
| MICRORNA-124 AS BIOMARKER | 2014 |
|
RU2687366C2 |
| RA ANTIGEN PEPTIDES | 2004 |
|
RU2359974C2 |
| SYSTEM (VARIANTS) AND METHOD OF DETECTING ANALYTE PRESENCE IN LIQUID SAMPLE | 2011 |
|
RU2653451C2 |
| METHOD FOR IDENTIFYING MUCOVISCIDOSIS CAUSING MUTATIONS IN CFTR HUMAN GENE, KIT OF PRIMERS, BIOCHIP, KIT OF TARGETS AND TEST SYSTEMS USED IN METHOD | 2012 |
|
RU2529717C2 |
| MULTIPARAMETRIC DIAGNOSTIC TEST SYSTEM FOR QUANTITATIVE DETERMINATION OF MRNA LEVEL OF HUMAN RIG-1, IFIT-1, IFIH-1 GENES | 2021 |
|
RU2782428C1 |
| MPHOSPH1 PEPTIDES AND VACCINES CONTAINING THEM | 2012 |
|
RU2612905C2 |
| TUBERCULOSIS BIOMARKERS | 2017 |
|
RU2756314C2 |
